The global pressure ulcer (PU) treatment market is expected to gain momentum from the rising adoption of innovative wound care devices for treatment. As per the Agency for Healthcare Research & Quality (AHRQ), in the U.S., more than 2.5 million people get affected by pressure ulcers annually. It proves that the increasing geriatric population, coupled with upsurging cases of PU would affect the market positively in the coming years.
This information is provided by Fortune Business Insights™ in a recent study, titled, “Pressure Ulcer (PU) Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Stage 1, Stage 2, Stage 3, Stage 4), By Product (Wound-care Dressings, Wound-care Devices, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026.” The study further states that the pressure ulcer treatment market size is projected to reach USD 11.23 billion by 2026, thereby exhibiting a CAGR of 6.7% during the forecast period. However, it stood at USD 6.69 billion in 2018.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pressure-ulcer-treatment-market-102095
Fortune Business Insights™ profiles some of the most reputed companies present in the pressure ulcer treatment market. They are as follows:
- Cardinal Health
- Braun Melsungen AG
- Braun Melsungen AG
- Coloplast Corp
- Tissue Regenix
- Smith & Nephew
- ConvaTec Group Plc
- Integra LifeSciences Corporation
- Other prominent players
The Report Answers the Following Questions:
- What are the most vital pressure ulcer market trends, opportunities, and challenges?
- How many growth drivers and hindrances will the market face?
- Which region will remain at the forefront throughout the forecast period?
- Which segment will dominate in terms of share?
- What are the strategies adopted by renowned companies to increase sales?
Rising Patent Pool Worldwide to Augment Growth
In the 20th century, a pressure ulcer was considered to be one of the costliest and the most physically debilitating complications. Factors, such as mobility problems, sedentary lifestyle, advancing age, and other similar health issues are mainly responsible for surging the incidence of PU worldwide. The National Center for Biotechnology Information (NCBI) declared that in 2018, the prevalence of pressure ulcers in Ethiopia, Turkey, and Brazil was 16%, 10.4%, and 12.7%, respectively. This indicates that there is a large patient pool seeking medical help across the globe. In addition to that, rising healthcare expenditure in the developing economies, as well as increasing awareness campaigns regarding the availability of various treatment options, would fuel the pressure ulcer treatment market growth during the forthcoming years.
Wound Care Dressings Segment to Lead Owing to their Higher Adoption
In terms of product type, the market is divided into wound care dressings, wound care devices, and others. Amongst these, the wound care dressings segment held 64.9% PU treatment market share in 2018 and is set to lead throughout the forecast period. This growth is attributable to their increasing adoption amongst the masses. They are the primary treatment option and help in speeding up the healing process
More Trending Topics from Fortune Business Insights: